We absolutely want this to proceed. What we don't believe is that there is a need for a production facility at this point.
That there is need for continued investment by Canada and the Gates Foundation in accelerating vaccine development, we are absolutely in agreement. Now, to what extent that happens in one centre, or in multiple centres, to what extent that happens more in Canada or more in Africa, those are exactly the kinds of questions that need to be worked out in terms of repurposing the construction of a manufacturing facility.
So whether that ends up being a centre of research or something else, that's exactly the kind of discussion we're in right now.